#United States #Palo Alto #Ethereum #ETHZilla #180 Life Sciences

180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy

On August 4, 2025, 180 Life Sciences Corp., trading on Nasdaq as ATNF and popularly known as ETHZilla, proudly announced the completion of a private placement. This strategic move saw the company raise a significant $425 million to fortify its aspirations surrounding Ethereum. The offering included a public equity transaction that involved the sale of common stock and pre-funded warrants at a purchase price of $2.65 per share.

The funds generated from this private placement will primarily be employed to enhance the company’s Ethereum (ETH) holdings further. This effort is part of a broader strategy that aims to integrate and affect the Ethereum ecosystem positively. The funds will also facilitate the coverage of transaction expenses, cash bonuses to select management members, support for the company's legacy iGaming operations, and further plans to monetize the company’s biotech intellectual property assets.

The company has recently appointed McAndrew Rudisill as Chairman of the Board, with Crystal Heter and Andrew Suckling joining as Independent Directors. This skilled team is expected to navigate the company through the evolving landscape of decentralized finance (DeFi) and Ethereum investments.

The private landscape was fostered by key partners like Electric Capital and Harbour Island, with significant involvement from notable figures in the cryptocurrency world. Notable participants include, but aren’t limited to, Borderless Capital, Polychain Capital, and Robert Leshner, among others, showcasing a strong network of institutional and crypto-native investors eager to support ETHZilla’s mission.

In a statement, McAndrew Rudisill expressed excitement about the collaboration with leading figures from the Ethereum community, emphasizing the collective goal to innovate and enhance the Ethereum network. The enthusiasm from industry leaders positions the company for substantial growth, setting a robust foundation for future endeavors.

Blair Jordan, CEO of ETHZilla, reflected on the positive feedback following the public announcement of the fundraising, indicating an optimistic outlook and commitment to delivering long-term shareholder value. He mentioned plans to begin ETH purchases decisively while maintaining core iGaming operations and pursuing strategic relationships within the biotechnology sector.

ETHZilla is committed to transparency, pledging to keep investors updated on its Ethereum holdings and other major developments. Following the primary private placement, there are plans for perhaps an additional $150 million in fixed income securities, subject to definitive agreements and documentation.

The company has engaged Electric Capital as its external asset manager, tasked with implementing an innovative yield generation program seeking to outperform traditional ETH staking strategies. This multifaceted approach will likely include various strategies such as staking, lending, liquidity provisioning, and bespoke agreements tailored for successful asset growth.

With the fresh capital in place, ETHZilla is not straying far from its roots as a biotechnology firm but is evolving into a dedicated ETH accumulation venture. By capitalizing on its strengths and realigning its focus toward Ethereum investments, the company aims to pave the way for efficient on-chain treasury management within public companies. This endeavor also highlights the intention to provide a vehicle for investors seeking exposure to the Ethereum blockchain’s vast potential.

In summary, 180 Life Sciences, transitioning into ETHZilla, is making calculated moves at an opportune moment in the cryptocurrency landscape. Through its ambitious treasury strategy and collaborative efforts with leading industry stakeholders, ETHZilla is positioned to become a quintessential example of how traditional companies can evolve and succeed in a decentralized environment, potentially leading to groundbreaking outcomes in the Ethereum ecosystem.

Forward-Looking Statements: This article contains forward-looking statements regarding the company's future intentions and expectations. Readers are advised to review comprehensive risk factors accompanying such projections outlined in the company’s filings with the SEC.